Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07444502) titled 'Safety Monitoring of Boostagen(R) Vaccine in Thailand' on Feb. 26.

Study Type: Observational

Primary Sponsor: BioNet-Asia Co., Ltd.

Condition: Pertussis (Whooping Cough) Tetanus Diphtheria

Recruitment Status: Not recruiting

Date of First Enrollment: June 30, 2017

Target Sample Size: 10727

Countries of Recruitment: Thailand

To know more, visit https://clinicaltrials.gov/study/NCT07444502

Published by HT Digital Content Services with permission from Health Daily Digest....